Morepen Laboratories Dividend & Ex-dividend History

MOREPENLAB • Dividend Analysis
Latest Dividend
₹0.2
0.59% Yield • 2025-March
Annual Payment

Morepen Laboratories (MOREPENLAB) has paid dividends for 1 years, annual and an average yield of 0.59% (10.0% consistency). The last dividend was ₹0.2 per share (2025-March, 0.59% yield), peak yield 0.59%.

Dividend Data Export

Dividend Summary

Latest Dividend ₹0.2
Average Dividend ₹0.2

Morepen Laboratories Dividend Per Share & Yield History

MOREPENLAB annual dividend per share (DPS) and dividend yield over 1 years. Check Morepen Laboratories market cap to track the company's total market size over time.

Morepen Laboratories Dividend Payment History

MOREPENLAB ex-dividend dates, dividend per share, yield and payment type — 10 records. For the full company profile including live price and ratios, see MOREPENLAB share price screener.

Year Period Dividend per Share Dividend Yield Payment Type
2026 March ₹0.00 0.00% Annual
2025 March ₹0.20 0.59% Annual
2024 March ₹0.00 0.00% Annual
2023 March ₹0.00 0.00% Annual
2022 March ₹0.00 0.00% Annual
2021 March ₹0.00 0.00% Annual
2020 March ₹0.00 0.00% Annual
2019 March ₹0.00 0.00% Annual
2018 March ₹0.00 0.00% Annual
2017 March ₹0.00 0.00% Annual

Frequently Asked Questions

Q: How much dividend does Morepen Laboratories pay?
Morepen Laboratories last paid a dividend of ₹0.2 with a yield of 0.59%. The company typically pays dividends annual.
Q: What is Morepen Laboratories dividend yield?
Morepen Laboratories has an average dividend yield of 0.59% based on historical data. The highest yield recorded was 0.59% and the lowest was 0.59%.
Q: How often does Morepen Laboratories pay dividends?
Morepen Laboratories typically pays dividends annual. The company has maintained a consistent payment frequency.
Q: Is Morepen Laboratories a good dividend stock?
Morepen Laboratories has paid dividends with 10.0% consistency over 10 years. The company has paid dividends in 1 out of 10 years tracked. Consider this alongside your investment goals and risk tolerance.